SCHEMBL30285660

SCHEMBL30285660

C=Cc1c(Oc2cccc(C(=N)N)c2)c(F)cc2[nH]ccc12

nearest known ligand 0.46

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ F10 P00742 17/20 0.46
▸ F2 P00734 7/20 0.46
▸ PRSS1 P07477 3/20 0.39
▸ PRSS2 P07478 1/20 0.39
▸ PRSS3 P35030 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29336712 1.00 F10 (0.46) F10F2PRSS1PRSS2PRSS3
SCHEMBL27276337 0.89 ASH1L (0.43) F10F2
SCHEMBL30750124 0.87 F10 (0.32) F10F2
SCHEMBL27282951 0.86 AKR1C3 (0.43) F10
SCHEMBL29237602 0.85 F10 (0.50) F10F2PRSS1PRSS2PRSS3
SCHEMBL30217327 0.85 F10 (0.50) F10F2PRSS1PRSS2PRSS3
SCHEMBL30805103 0.84 TRPA1 (0.33) —
SCHEMBL27265131 0.84 TRPA1 (0.33) —
SCHEMBL30285603 0.84 F10 (0.53) F10F2PRSS1PRSS2PRSS3
SCHEMBL30967772 0.84 F10 (0.48) F10F2PRSS1PRSS2PRSS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4396176-A1 INDOLE COMPOUNDS AND USES THEREOF IN THE TREATEMENT OF CYSTIC FIBROSIS GENZYME CORPORATION (US) 2024-07-10 — — EP disclosed
WO-2023034946-A1 INDOLE COMPOUNDS AND USES THEREOF IN THE TREATEMENT OF CYSTIC FIBROSIS GENZYME CORPORATION (US) 2023-03-09 — — WO disclosed
Send feedback